Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:52:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T02:15:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:18:21.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a Phase I/II trial for indoximod in combination with chemotherapy for metastatic pancreatic adenocarcinoma, while adding a new version number and the term 'Metastatic Pancreatic Adenocarcinoma'.
    Difference
    28%
    Check dated 2025-04-16T20:27:39.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:31:34.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:58:03.000Z thumbnail image

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.